Upto Date
New Delhi: In the world of Indian entrepreneurship, Pankaj Patel stands as a symbol of quiet determination and steady progress. Born in 1951 in Karamsad, Gujarat, Patel’s journey from a…
NEW DELHI: Drug firm Zydus Cadila on Thursday said it has received final approval from the US health regulator to market Nelarabine injection, used to treat certain types of cancer,…
The Chairman of the National Technical Advisory Group on Immunization, NK Arora, said on August 23, 2021, that the children with comorbidities will be given the priority in vaccination drive…
Zydus Cadila’s ZyCoV-D, the world’s first plasmid-DNA three-dose COVID-19 vaccine on August 20, 2021, received Emergency-Use Authorization (EUA) from the Drugs Controller General of India (DCGI) to be administered in…
Zydus Cadila’s three-dose COVID-19 vaccine, ZyCoV-D is expected to get emergency use approval later this week, informed sources. ZyCoV-D is the world’s first plasmid DNA vaccine against COVID-19. Union Health…
A bench consisting of Chief Justice D N Patel and Justice Jyoti Singh observed, “Let the clinical trials be done, otherwise it will be a disaster if the COVID vaccines…
Zydus Cadila, the Ahmedabad-based pharmaceutical firm on June 18, 2021, is likely to apply to the Drug Controller General of India (DCGI) seeking emergency use authorization for its COVID-19 vaccine…
NEW DELHI: Congress leader Priyanka gandhi Vadra on Friday questioned the center that why it is dependent on other countries for Covid vaccines when India is of the biggest exporters…
BENGALURU: India’s Zydus cadila has sought regulatory approval for clinical trials of its antibody cocktail to treat mild Covid-19, as the country grapples with a shortage of medicines and vaccines…
Zydus Cadila announced on May 26, 2021, that the company is seeking approval from the Drugs Controller General of India (DCGI) to conduct clinical trials of its monoclonal antibody therapy…